Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
146.10
-0.28 (-0.19%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Neurocrine Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $204 | Buy | Reiterates | $204 | +39.63% | Oct 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $200 | Buy | Maintains | $200 | +36.89% | Oct 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $187 | Buy | Maintains | $187 | +27.99% | Oct 13, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $164 → $150 | Hold | Maintains | $164 → $150 | +2.67% | Oct 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $214 | Buy | Reiterates | $214 | +46.48% | Oct 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $210 | Buy | Reiterates | $210 | +43.74% | Oct 9, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $207 | Buy | Initiates | $207 | +41.68% | Oct 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $220 | Buy | Maintains | $220 | +50.58% | Sep 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.